The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shabalina D.O.

Voino-Yasenetsky Krasnoyarsk State Medical University

Zulkaidarova A.R.

Voino-Yasenetsky Krasnoyarsk State Medical University

Khramchenko M.A.

Voino-Yasenetsky Krasnoyarsk State Medical University

Subocheva S.A.

Voino-Yasenetsky Krasnoyarsk State Medical University

Abroskina M.V.

Voino-Yasenetsky Krasnoyarsk State Medical University

Prokopenko S.V.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Experience of remote rehabilitation for patients with multiple sclerosis

Authors:

Shabalina D.O., Zulkaidarova A.R., Khramchenko M.A., Subocheva S.A., Abroskina M.V., Prokopenko S.V.

More about the authors

Read: 1877 times


To cite this article:

Shabalina DO, Zulkaidarova AR, Khramchenko MA, Subocheva SA, Abroskina MV, Prokopenko SV. Experience of remote rehabilitation for patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):69‑73. (In Russ.)
https://doi.org/10.17116/jnevro202212211169

Recommended articles:
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

References:

  1. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sciences. 2020;10(5):305.  https://doi.org/10.3390/brainsci10050305
  2. Nikonova EV, Abdullayev MB, Pervunina AV, Abroskina MV. Work experience of the demyelination pathology unit in the city of Krasnoyarsk related to investigation of the quality of life of patients with multiple sclerosis. Siberian Medical Review. 2021;(3):73-79. (In Russ.). https://doi.org/10.20333/25000136-2021-3-73-79
  3. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.  https://doi.org/10.1016/S1474-4422(17)30470-2
  4. Boyko A, Kobelt G, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe: Results for Russia. Mult Scler. 2017;23(2 suppl):155-165.  https://doi.org/10.1177/1352458517708668
  5. Hauser L, Cree B. Treatment of Multiple Sclerosis: A Review. Am J Med. 2020;133(12):1380-1390. https://doi.org/10.1016/j.amjmed.2020.05.049
  6. Soelberg Sorensen P, Giovannoni G, Montalban X, et al. The Multiple Sclerosis Care Unit. Mult Scler. 2019;25(5):627-636.  https://doi.org/10.1177/1352458518807082
  7. Sorensen PS, Sellebjerg F, Hartung HP, et al. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. Brain. 2020;143(9):2637-2652. https://doi.org/10.1093/brain/awaa145
  8. Li H, Hu F, Zhang Y, Li K. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis. J Neurol. 2020;267(12):3489-3498. https://doi.org/10.1007/s00415-019-09395-w
  9. Vargas DL, Tyor WR. Update on disease-modifying therapies for multiple sclerosis. J Investig Med. 2017;65(5):883-891.  https://doi.org/10.1136/jim-2016-000339
  10. Díaz C, Zarco LA, Rivera DM. Highly active multiple sclerosis: An update. Mult Scler Relat Disord. 2019;30:215-224.  https://doi.org/10.1016/j.msard.2019.01.039
  11. Gholamzad M, Ebtekar M, Ardestani MS, et al. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res. 2019;68(1):25-38.  https://doi.org/10.1007/s00011-018-1185-0
  12. Learmonth YC, Kaur I, Baynton SL, et al. Changing Behaviour towards Aerobic and Strength Exercise (BASE): Design of a randomised, phase I study determining the safety, feasibility and consumer-evaluation of a remotely-delivered exercise programme in persons with multiple sclerosis. Contemp Clin Trials. 2021;102:106281. https://doi.org/10.1016/j.cct.2021.106281
  13. Kubsik-Gidlewska AM, Klimkiewicz P, Klimkiewicz R, et al. Rehabilitation in multiple sclerosis. Adv Clin Exp Med. 2017;26(4):709-715.  https://doi.org/10.17219/acem/62329
  14. Amatya B, Khan F, Galea M. Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2019;1(1):CD012732. https://doi.org/10.1002/14651858.CD012732.pub2
  15. McEwan D, Rhodes RE, Beauchamp MR. What Happens When the Party is Over?: Sustaining Physical Activity Behaviors after Intervention Cessation. Behavioral Med. 2020;34(8):1-9.  https://doi.org/10.1080/08964289.2020.1750335
  16. Voigt I, Benedict M, Susky M, et al. A Digital Patient Portal for Patients With Multiple Sclerosis. Frontier Neurol. 2020;11:400.  https://doi.org/10.3389/fneur.2020.00400
  17. Isernia S, Pagliari C, Jonsdottir J, et al. Efficiency and Patient-Reported Outcome Measures From Clinic to Home: The Human Empowerment Aging and Disability Program for Digital-Health Rehabilitation. Front Neurol. 2019;10:1206. https://doi.org/10.3389/fneur.2019.01206
  18. Chirra M, Marsili L, Wattley L, et al. Telemedicine in Neurological Disorders: Opportunities and Challenges. Telemed J E Health. 2019;25(7):541-550.  https://doi.org/10.1089/tmj.2018.0101
  19. Fjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. Int J Telerehabil. 2018;10(2):55-64.  https://doi.org/10.5195/ijt.2018.6256
  20. Di Tella S, Pagliari C, Blasi V, et al. Integrated telerehabilitation approach in multiple sclerosis: A systematic review and meta-analysis. J Telemed Telecare. 2020;26(7-8):385-399.  https://doi.org/10.1177/1357633X19850381
  21. Plow M, Motl RW, Finlayson M, et al. Response heterogeneity in a randomized controlled trial of telerehabilitation interventions among adults with multiple sclerosis. J Telemed Telecare. 2020;1357633X20964693. https://doi.org/10.1177/1357633X20964693
  22. Amatya B, Galea MP, Kesselring J, et al. Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review. Mult Scler Relat Disord. 2015;4(4):358-369.  https://doi.org/10.1016/j.msard.2015.06.011

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.